cephalexin + desonide + triamcinolone

Cephalexin + desonide + triamcinolone is a combination of three active pharmaceutical ingredients, each with distinct mechanisms and indications. Cephalexin is a first-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis, leading to cell lysis and death; it is primarily used for treating infections caused by susceptible bacteria, including skin and soft tissue infections[2][6]. Desonide is a low-potency topical corticosteroid that reduces inflammation and itching in various dermatological conditions such as eczema or dermatitis by suppressing the release of inflammatory mediators[4]. Triamcinolone is a medium- to high-potency topical corticosteroid used for similar inflammatory skin conditions; it works by reducing inflammation, redness, and irritation through inhibition of multiple inflammatory cytokines[4]. This combination would theoretically provide both antimicrobial action (cephalexin) and anti-inflammatory effects (desonide, triamcinolone), potentially useful in mixed infectious/inflammatory dermatoses.